Cogstate is the leader in Cognitive Assessment. Its customers are some of the world’s largest pharmaceutical and biotech companies and CROs.
The Cognitive and Assessment and Training market is projected to grow from 2.4 billion (in 2015) to 7.5 billion (by 2020).
The company has a strong legacy of scientific excellence, facilitating current focus on business development and product development.
94% of Cogsgate’s revenue in the first half of FY16 comes from clinical trials, where revenue is driven by volume and size of trials. Outsourcing growth trends are expected to continue in clinical trials.